Company Analysis China Shineway Pharmaceutical Group Ltd ADR
1. Summary
Advantages
- Price (19.25 $) is less than fair price (29.15 $)
- Dividends (7.36%) are higher than the sector average (4.25%).
- The stock's return over the last year (3.89%) is higher than the sector average (0%).
- Current debt level 3.45% is below 100% and has decreased over 5 years from 231.87%.
- The company's current efficiency (ROE=11.59%) is higher than the sector average (ROE=9.99%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| China Shineway Pharmaceutical Group Ltd ADR | Index | ||
|---|---|---|---|
| 7 days | 0% | 0.5% | 0.6% |
| 90 days | 0% | 1.1% | 1.6% |
| 1 year | 3.9% | 0% | 15.1% |
CSWYY vs Sector: China Shineway Pharmaceutical Group Ltd ADR has outperformed the "" sector by 3.89% over the past year.
CSWYY vs Market: China Shineway Pharmaceutical Group Ltd ADR has significantly underperformed the market by -11.26% over the past year.
Stable price: CSWYY is not significantly more volatile than the rest of the market on "USA Stocks" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CSWYY with weekly volatility of 0.0747% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (19.25 $) is lower than the fair price (29.15 $).
Price significantly below the fair price: The current price (19.25 $) is 51.4% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (0.3) is lower than that of the sector as a whole (231.08).
P/E vs Market: The company's P/E (0.3) is lower than that of the market as a whole (141.31).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (0.0342) is lower than that of the sector as a whole (3.54).
P/BV vs Market: The company's P/BV (0.0342) is lower than that of the market as a whole (2.85).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0.0676) is lower than that of the sector as a whole (12.89).
P/S vs Market: The company's P/S indicator (0.0676) is lower than that of the market as a whole (5.44).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-4.54) is lower than that of the sector as a whole (11.15).
EV/Ebitda vs Market: The company's EV/Ebitda (-4.54) is lower than that of the market as a whole (12.49).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 174.65% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (174.65%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0%).
6.4. ROE
ROE vs Sector: The company's ROE (11.59%) is higher than that of the sector as a whole (9.99%).
ROE vs Market: The company's ROE (11.59%) is lower than that of the market as a whole (190.51%).
6.6. ROA
ROA vs Sector: The company's ROA (8.57%) is higher than that of the sector as a whole (0.43%).
ROA vs Market: The company's ROA (8.57%) is lower than that of the market as a whole (173.11%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.35%).
8. Dividends
8.1. Dividend yield vs Market
High yield: The dividend yield of the company 7.36% is higher than the average for the sector '4.25%.
8.2. Stability and increase in payments
Dividend stability: The company's dividend yield 7.36% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 7.36% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (48.56%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
